- Home
- NEU vs GH Comparison
NEU vs GH Comparison
Compare NEU & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEU
- GH
- Stock Information
- Founded
- NEU 1887
- GH 2011
- Country
- NEU United States
- GH United States
- Employees
- NEU N/A
- GH N/A
- Industry
- NEU Major Chemicals
- GH Medical Specialities
- Sector
- NEU Industrials
- GH Health Care
- Exchange
- NEU Nasdaq
- GH Nasdaq
- Market Cap
- NEU 5.4B
- GH 4.9B
- IPO Year
- NEU N/A
- GH 2018
- Fundamental
- Price
- NEU $644.06
- GH $40.18
- Analyst Decision
- NEU
- GH Strong Buy
- Analyst Count
- NEU 0
- GH 21
- Target Price
- NEU N/A
- GH $52.81
- AVG Volume (30 Days)
- NEU 36.6K
- GH 2.3M
- Earning Date
- NEU 07-28-2025
- GH 04-30-2025
- Dividend Yield
- NEU 1.71%
- GH N/A
- EPS Growth
- NEU 20.83
- GH N/A
- EPS
- NEU 50.24
- GH N/A
- Revenue
- NEU $2,790,768,000.00
- GH $773,996,000.00
- Revenue This Year
- NEU N/A
- GH $23.05
- Revenue Next Year
- NEU N/A
- GH $21.40
- P/E Ratio
- NEU $12.82
- GH N/A
- Revenue Growth
- NEU 3.65
- GH 28.20
- 52 Week Low
- NEU $480.00
- GH $20.14
- 52 Week High
- NEU $653.71
- GH $52.92
- Technical
- Relative Strength Index (RSI)
- NEU 62.29
- GH 47.02
- Support Level
- NEU $630.79
- GH $37.73
- Resistance Level
- NEU $646.44
- GH $39.63
- Average True Range (ATR)
- NEU 8.79
- GH 1.56
- MACD
- NEU -3.29
- GH 0.11
- Stochastic Oscillator
- NEU 61.08
- GH 63.25
About NEU NewMarket Corp
NewMarket Corp is a holding company that, through its subsidiaries, manufactures and sells petroleum additives. Petroleum additives are used in lubricating oils and fuels to enhance their performance in machinery, vehicles, and other equipment. It comprises two broad product applications. Lubricant additives are formulated chemical solutions that, when blended with base fluids, improve the efficiency, durability, performance, and functionality of mineral oils, synthetic oils, and biodegradable fluids. Fuel additives are chemical components that help oil refiners meet fuel specifications or formulated packages that improve the performance of gasoline, diesel, biofuels, and other fuels.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.